logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
Clinical and Translational Oncology cover

Clinical and Translational Oncology

IF2.5
Papers838
Citations5617
Journal Papers 761
Publication Date
delete
Expert opinion document on the management of desmoid tumours in adult patients in Spain
deleteClinical and Translational Oncology
IF2.5
delete2026-07-11
delete0
deleteOAAI
deleteRosa María Álvarez Álvarez; Javier Zenón Martín Broto; Javier Martínez Trufero; Ana Sebio García; Claudia María Valverde Morales; Jorge García López; Celia Martín Machín; Alicia Gil
deleteShare
deleteSave
Fusobacterium nucleatum, succinate signaling, and immunotherapy resistance in colorectal cancer: clinical relevance and translational opportunities
deleteClinical and Translational Oncology
IF2.5
delete2026-07-11
delete0
PREAI
deleteJiaqi Niu; Weitong Sun; Ruiqian Gong; Qingchun Pan
deleteShare
deleteSave
Cost-effectiveness of first-line treatments for metastatic pancreatic cancer
deleteClinical and Translational Oncology
IF2.5
delete2026-07-10
delete0
PREAI
deleteYing Dong; Yiqing Yin; Guiyue Wang; Gengwei Huo
deleteShare
deleteSave
A systematic review and meta-analysis on survival, pathological response, and safety of durvalumab in early-stage non-small cell lung cancer
deleteClinical and Translational Oncology
IF2.5
delete2026-07-10
delete0
PREAI
deleteMuhammad Imran; Aziz Naeem; Najmus Saqib; Asma Ehsan Abbasi; Aneesa Sultan
deleteShare
deleteSave
Active recruitment for vaccination of patients with solid-organ cancer through the surgical pathway
deleteClinical and Translational Oncology
IF2.5
delete2026-07-09
delete0
PREAI
deleteMaría Fernández-Prada; Paula Cienfuegos-González; María José Zapico-Baragaño
deleteShare
deleteSave
Revealing the dynamics of follicular T cells and checkpoint engagement in surgically resected colorectal cancer and their relations to clinicopathological aspects
deleteClinical and Translational Oncology
IF2.5
delete2026-07-08
delete0
PREAI
deleteAsmaa M. Zahran; Nahla M. Elsherbiny; Alshimaa G. Abdelhakeem; Amal Rayan; Zainab Gaber Mahran; Ahmed Khalid Ibrahim Elsayh; Emad Saad; Ahmed Refaat; Radwan Abdelsabour; Doaa A. Gamal; Wageeh A. Ali; Zeinab Albadry M. Zahran; Hossam Elashmawy; Shimaa Gafar Mansor
deleteShare
deleteSave
Risk prediction of non-small cell lung cancer in patients with pulmonary nodules: a single-center cohort study based on six machine learning algorithms
deleteClinical and Translational Oncology
IF2.5
delete2026-07-08
delete0
PREAI
deleteZhibo Liu; Xiaowan Xu; Shihao Zhou; Deyan Fan; Xinyao Liu
deleteShare
deleteSave
Prophylactic cranial irradiation in the era of immunotherapy in extensive-stage small cell lung cancer: a systematic review and meta-analysis
deleteClinical and Translational Oncology
IF2.5
delete2026-07-07
delete0
deleteOAAI
deleteDominik Wróbel; Patryk Rogaczewski; Natalia Ostruszka; Jędrzej Borowczak; Artur Bandura; Paweł Michał Potocki
deleteShare
deleteSave
Circulating serum microRNAs in kidney transplant recipients with post-transplant malignancies
deleteClinical and Translational Oncology
IF2.5
delete2026-07-07
delete0
deleteOAAI
deleteRoger Bakekolo; Henrietta Gellen; Katalin Gombos; Karoly Kalmár Nagy; Peter Szakaly; Adam Varga
deleteShare
deleteSave
Impact of post-total thyroidectomy thyroglobulin levels on recurrence in patients with differentiated  thyroid cancer at a tertiary care center in Mexico
deleteClinical and Translational Oncology
IF2.5
delete2026-07-07
delete0
PREAI
deleteAna Victoria Espinosa de los Monteros Gonzalez; Martin Verdin Gonzalez; Jose Antonio Villegas Velazquez
deleteShare
deleteSave
Renal toxicity during VEGF-pathway inhibition in cancer: a practical review of proteinuria, hypertension, and kidney-limited thrombotic microangiopathy
deleteClinical and Translational Oncology
IF2.5
delete2026-07-06
delete0
deleteOAAI
deleteLucas Maciel de Almeida Corrêa; Ana Laura Mendes Lourenço; Luiggi Kevin Virgino Brandão; Gabriel Rian Mazur; Alexandre de Assis Barbosa; Clara Belo Gamon Santiago; Ivan Felipe Dutra Júnior; Rodrigo Galetto Husch; Yan Roberth Delmiro Silva; Gabriel Costa de Santana; Letícia Esteves Dante
deleteShare
deleteSave
Multidisciplinary management of advanced ovarian cancer in Spain: expert recommendations for achieving maximum survival and improving patient care
deleteClinical and Translational Oncology
IF2.5
delete2026-07-06
delete0
deleteOAAI
deleteMaria-Pilar Barretina-Ginesta; Ainhoa Madariaga; Manel Barahona Orpinell; Alejandro Gallego; Eva María Guerra Alía; Xavier Matias-Guiu; Ana Beatriz Sanchez Heras; Soraya Casla-Barrio; Fátima Castaño; Melinda Gonzalez Concepción; Mar Navarro López; Charo Hierro Racionero; Marcelo Ruz Torres; Lydia Gaba García
deleteShare
deleteSave
Association of pathological response with long-term survival after neoadjuvant chemo-immunotherapy in resectable oesophageal squamous cell carcinoma: a systematic review and individual-patient-data meta-analysis
deleteClinical and Translational Oncology
IF2.5
delete2026-07-06
delete0
PREAI
deleteRuiying Zhang; Zhe Wang; Lulu Guan; Bingtong Yue; Dao Xin; Feng Wang
deleteShare
deleteSave
Concordance between multidisciplinary tumor board decisions and AI-based recommendations in endometrial cancer: impact of discordance direction on clinical outcomes
deleteClinical and Translational Oncology
IF2.5
delete2026-07-05
delete0
PREAI
deleteVali Aliyev; Selin Cebeci; Zeliha Birsin; Murat Günaltılı; Mehmet Cem Fidan; Emir Çerme; Hamza Abbasov; Şefika Arzu Ergen; Nebi Serkan Demirci; Özkan Alan
deleteShare
deleteSave
The preventable burden of tobacco-attributable cancer incidence in Catalonia (Spain) in 2024: a Bayesian approach
deleteClinical and Translational Oncology
IF2.5
delete2026-07-05
delete0
PREAI
deleteRamon Clèries; Joan Martínez; Alberto Ameijide; Jan Trallero; Arantza Sanvicens; Isaac Torres; Marià Carulla; Maria Buxó; Josep Alfons Espinàs; Pere Godoy; Rafael Marcos-Gragera; Jaume Galceran; Josep Maria Borràs
deleteShare
deleteSave
External validation of a nomogram for de novo bone metastasis in breast cancer: a single-center Mexican cohort
deleteClinical and Translational Oncology
IF2.5
delete2026-07-04
delete0
PREAI
deleteAdrián Canizalez-Román; Romina Llanes-Cardenas; Francisco Antonio Martínez-Villa; Diego Arriaga-Izabal
deleteShare
deleteSave
Efficacy and safety of second-line treatments in ALK mutation-positive advanced non-small cell lung cancer after second- or third-generation ALK inhibitors: Turkish Oncology Group real-life study (TOG study)
deleteClinical and Translational Oncology
IF2.5
delete2026-07-04
delete0
PREAI
deleteCihan Erol; Esra Zeynelgil; Mutlu Hizal; Aysegul Dumludag; Mert Erciyestepe; Ender Kalaci; Sedat Biter; Teoman Sakalar; Merve Keskinkılıc; Seda Kahraman; Selver Isik; Pinar Gursoy; Yasin Kutlu; Yakup Ergun; Ilknur Deliktas; Oguzhan Yildiz; Murat Araz; Sinem Akbas; Pervin Can Sanci; Kazim Uygun; Ziya Kalkan; Dogan Bayram; Dogan Uncu; Sila Oksuz; Nedim Turan; Ozturk Ates; Ahmet Bilici; Saadettin Kilickap; Ilhan Oztop; Serdar Karakaya; Semra Paydas; Ahmet Demirkazik; Nuri Karadurmus; Mehmet Ali Nahit Sendur
deleteShare
deleteSave
Clinical and pathologic insights into early and late breast cancer relapses: a real-world analysis from the El Álamo IV registry
deleteClinical and Translational Oncology
IF2.5
delete2026-07-03
delete0
deleteOAAI
deleteLucía Fraile-Lara; Raquel Andrés; Sonia Servitja; Eva Carrasco; Ángel Guerrero; Begoña Bermejo; Antonio Antón; Josefina Cruz; Isabel Álvarez; David Aguiar; Purificación Martínez; Álvaro Rodríguez-Lescure; Andrea Blasco; Miguel Martín; Sara López-Tarruella
deleteShare
deleteSave
Neoadjuvant metformin on clinical and pathological response in non-diabetic patients with non-metastatic breast cancer: an updated systematic review and meta-analysis
deleteClinical and Translational Oncology
IF2.5
delete2026-07-03
delete0
PREAI
deleteDiego Arriaga‐Izabal; Francisco Morales‐Lazcano; Uriel A. Angulo-Zamudio; Adrian Canizalez-Román; Nidia León-Sicairos
deleteShare
deleteSave
Comparative effectiveness of two alternative dosing strategies of pembrolizumab in metastatic non-small-cell lung cancer in a real-world setting
deleteClinical and Translational Oncology
IF2.5
delete2026-07-01
delete0
PREAI
deleteMargarita Garrido-Siles; Jose Carlos Benitez; Elena Alvaro Sanz; Andres Mesas Ruiz; Manuel Cobo Dols; Beatriz Mora Rodriguez; Sonia Gonzalez; Eduardo Zamorano Gonzalez; Victor Navarro Pérez; Lidia Perez Villa; Andres Gonzalez Jimenez; Isabel Moya Carmona; Emilio Alba Conejo; Antonio Rueda Dominguez
deleteShare
deleteSave